Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents. 1986

J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple

Members of the series of title compounds were tested for potential antipsychotic activity in relevant receptor binding assays and behavioral screens. Structure-activity relationships within the series are discussed. Compound 24 (BMY 13859-1), a (1,2-benzisothiazol-3-yl)piperazine derivative, was selected for further study because of its potent and selective profile in primary CNS tests. It was active in the Sidman avoidance paradigm and blocked amphetamine-induced stereotyped behavior in dogs for up to 7 h. The compound's lack of typical neuroleptic-like effects in the rat catalepsy test and its failure to produce dopamine receptor supersensitivity following chronic administration indicate that it should not cause the movement disorders commonly associated with antipsychotic therapy. Although 24 has potent affinity for dopaminergic binding sites, its even greater affinity for serotonin receptors suggests that a serotonergic component may be relevant to its atypical profile. Compound 24 is currently undergoing clinical evaluation in schizophrenic patients.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine

Related Publications

J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
September 2023, Bioorganic & medicinal chemistry letters,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
August 1999, Farmaco (Societa chimica italiana : 1989),
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
March 2017, Chemical biology & drug design,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
June 2013, Bioorganic & medicinal chemistry,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
July 2023, Bioorganic chemistry,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
December 1995, Chemical & pharmaceutical bulletin,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
December 2014, Bioorganic & medicinal chemistry,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
February 2014, Bioorganic & medicinal chemistry letters,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
January 2022, Frontiers in chemistry,
J P Yevich, and J S New, and D W Smith, and W G Lobeck, and J D Catt, and J L Minielli, and M S Eison, and D P Taylor, and L A Riblet, and D L Temple
January 1997, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!